frisko6@yahoo.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mazars is HUGE, worldwide, they got an office in NJ. too, looks like an upgrade to me.
https://www.mazars.us/Offices/New-Jersey
and downtown manhattan
Bubba was right, it was a misprint, Mazars is out of NY,
From the OTC
https://www.otcmarkets.com/stock/ELTP/profile
That makes me feel better, what a shock. Mazars are top-notch/
A misspelling is easy with this one
Thats Mazars, check the spelling, Elite hired Mazers, looks like out of Boca Raton
https://www.mazercpa.com/
number 1
look at the prices for Walgreens DexAmp, it's huge
https://www.walgreens.com/images/adaptive/pdf/Walgreens-Plus_Drug-List_20180321.pdf
Mr. Kirkov must have gotten some big orders, their hiring more people
https://www.indeed.com/cmp/Elite-Pharmaceuticals,-Inc.-1/jobs
Lannett got a good write-up here.
https://www.drugs.com/answers/best-generic-brand-adderall-30mg-3460333.html
Elite makes a good product .
Bartells , Seattle, out of stock
https://www.bartelldrugs.com/pointy?query=generic+adderall&store-id=&clear=false
From a recent report.
The report notes that, overall, the percentage of enrollees who had prescriptions for stimulants and were in employer-sponsored health plans increased from 3.6% in 2016 to 4.1% in 2021.
this is important to Mr. Kirkov, were talking CO-PAY
https://www.marylandmatters.org/2023/07/11/shortage-of-drugs-to-treat-adhd-continues-as-studies-indicate-increase-in-prescriptions/
On yahoo fins. They finaly brought it up to 53 employees.
Thx, amother peice of the puzzle.
From a new article
For Dr. Clark’s pharmacy, he has been able to meet many of his customers’ needs by simply buying Adderall from wholesalers as soon as they become available.
Biloxi blues
https://www.msn.com/en-us/health/medical/adderall-shortage-continues-around-the-state/ar-AA1dBuxI
I just saw 4 cents, WOW
Were getting some Volume, it could break 4 cents today
And enter Mr. Kirkov, I expect him to put out a little Pub/Splash.
OKY DOAKY
Yep, you are absolutely correct.
In addition, the company submitted partial ANDA for pain management for review by FDA. The partial application contains the recently conducted insufflation study. Elite intends to provide the FDA with the remaining data in Q3 of 2023 to complete this filing. We disclosed a while back that we're actually continued working on a generic version of Oxycodone. And the last time we filed it, we had deficiencies and one of the deficiencies that everybody got is that an insufflation study was not conducted. It was cost prohibitive. That study alone is about $1.5 million, $2 million, and this is why we put the project on hold.
you just keep believing that.
Also, if you are the first to file , you get 180 start on everybody else, If I'm reading this right
Note: As outlined in the Proposed Criteria for First Generic Submissions for Purposes of ANDA, certain ANDAs are deemed “first generic” for the purposes of review prioritization. In this context, a first generic application is any received ANDA: (1) That is a first-to-file ANDA eligible for 180-day exclusivity, or for which there are no blocking patents or exclusivities; and (2) for which there is no previously-approved ANDA for the drug product.
from this link:
https://www.fda.gov/drugs/drug-and-biologic-approval-and-ind-activity-reports/first-generic-drug-approvals
Elite is a strong buy candidate
https://stockinvest.us/stock/ELTP
I dont see Elite on this list
https://pink.pharmaintelligence.informa.com/PS120021/Complete-Response-Letters
Thanks rdfdr1, not the most flattering report, but they leave out the intangibles, we all know what's happening with the transition, The next Q will give us a better perspective., looks like the middle of Aug. for the next report.
Not just another article, the last paragraph got to me, I know people in that condition.
https://www.nationalgeographic.com/premium/article/adderall-shortage-adult-adhd
What is 6.68% of the IR market
And for the month of April, for the IR, were on command with 6.68% of the market. I definitely expect that number to improve
I didn't calculate , but they made just a little 9 mill and change, didn't break 10 mill, for the first 3 months of this year,
one of these Q's I will be right
but still, looking good, they got the hottest drugs on the market, every body wants a piece of Elite
the future looks bright
Nice, Employees up to 53 now, and the investment in a sales and distribution organization, should be a one time charge.
they are selling the hottest drug on the market right now, the buyers will come knocking on Elites door. Should be no problem.
You got my respect, you've.been doing this for years
I have so many questions for the CC, don't know where to start'
1: how is Mr Kirkov doing with sales
2: did we get paid from Lannett, and why on Lanntt's site does it say we still make the generic Add.
3: How is the transition going, make any big deals yet ?
so many questions, so little time,
OH what about API ?
well any way, I won't E-mail Dianne, these questions are obvious, just hope we get some guidance from Nasrat
dianne@elitepharma.com
General questions by 5:00 PM EDT on Wednesday, June 28, 2023
Financial questions by 7:00 PM EDT on Thursday, June 29, 2023
Round up the usual suspects
OH sorry, didn't know, I looked at Sunrise as sort of an Ackme pill stamper, just for reference
they have been on the shortage page for about 9 months
but what I was trying to say is , Why hasn't one of the big boys bought them out, just to get in the game,
because of the DEA, limits on the API,
don't ya think they would all be there,
SHUT ME UP
To add to the conversation . my 2 cents
I ck the shortage page daily noticed USPHARMA last, under Teva, came on way back in Dec. or so, 4 months later they shot their wad, now they gotta wait, Sunrise came on, says they are current, no shortage, never heard of Sunrise, looked into, I think they have 5 employees , their stock is in storage, so they say YES, we got plenty,
So what I'm driving at is, Why didn't Pfizer or JNJ or Opko, swoop down and buy them out, just to get in the game, Reason,
The DEA , If PFE was to buy a new kid on the block, they would have to wait years, to prove sales,
just like the rest of us
https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
There is a lot of talk now, on the hill, about shortages
https://www.cidrap.umn.edu/resilient-drug-supply/us-policymakers-acting-bolster-drug-supply-chains-amid-critical-shortages
Enter Mr. Kirkov, stage left.
Lannett on the shortage page, new update, they are Golden,
https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
https://www.lannett.com/products/
So at first glance, it tells me, they are using left over API, from Elite, to complete the run, but that should have been done months ago, unless they made a deal with the FDA, because of the nation wide shortage, which if OK, by me, but will we get paid from Lannett, now that they are in BK. That is the question ?
Not quite sure what you mean, but if you go to Lannetts product page you will see both tabs and caps being made by both company's at the same time. ODD
https://www.lannett.com/products/
It would also be nice if the DEA would open up the flood gates on the API.
New on shortage, now TaKeda out of Japan is having a problem, and according to this article the white house is getting involved.
https://fortune.com/well/2023/06/20/adderall-alternative-vyvanse-adhd-drug-shortages/
They are hiring more people, just added another one today.
https://www.indeed.com/cmp/Elite-Pharmaceuticals,-Inc.-1/jobs